- Text-only version of this website
- Skip navigation
- Home page
- What's new
- Search
- Contact Webmaster
- Website policies
- Disability services
UF study questions accuracy of CMS opioid safeguards
The Centers for Medicare and Medicaid Services criteria are used to flag high-risk patients for opioid abuse and overdose.
Dr. Scott Martin Vouri named a Claude D. Pepper Junior Scholar
The distinction comes with a two-year, $104,000 award, which Vouri will use to study a type of drug-induced adverse event called a prescribing cascade in older adults.
Dr. Amie Goodin featured in NY Times story on the opioid crisis
“Current policies to limit opioid prescriptions leave some pain patients high and dry, resulting in a new wave of unintended consequences for patients with untreated chronic pain.”
Center for Drug Evaluation and Safety established at the University of Florida
The center will unite researchers interested in using big data to evaluate drugs and the safety of medications in real-world populations.
New treatment for hepatitis C results in lower costs overall
The study, published in the journal Hepatology, examined the clinical and economic outcomes of direct-acting antiviral therapy, which cures hepatitis C in nearly 95 percent of patients.
College of Pharmacy’s Yan Li Earns Top Honors at the 32nd Annual Research Showcase
The Department of Pharmaceutical Outcomes & Policy is proud to announce that Yan Li was the winner of the 2019 poster competition in the category of “Pain, Addiction, and CNS […]
Welcome to the Department of Pharmaceutical Outcomes and Policy
Thank you for your interest in our department, and our outstanding faculty, students and staff who represent our broad range of programs and resources. Faculty are actively engaged in the entry-level Pharm.D. program and our own graduate program, including one of the nation’s largest Ph.D. programs in pharmaceutical outcomes and policy, a research-focused residential M.S. program and an applied online M.S. program geared toward working professionals.
The department’s focus in research and graduate training is centered on the evaluation of drugs and related medical technology. This focus includes classic pharmacoepidemiologic and pharmacoeconomic work, as well as pharmaceutical health services research with a focus on quality and policy involving medication use. Our program has grown tremendously over the past five years with more to come. To find out more, please refer to our annual report and reach out or visit us in beautiful Florida to see one of the nation’s top 10 universities and top 10 pharmacy colleges.
Almut G. Winterstein, Ph.D.
Department Chair
2018 Annual Report
Events
POP Seminar Announcement: Yushi Huang
Yushi Huang is a first year PhD student, who entered the POP program in the Fall 2018. Yushi is originally from China, but traveled to the United States to attend […]
POP Seminar Announcement: Phuong (Phoenix) Tran & Ching-Yuan (Peggy) Chang
Phuong is a first year PhD student in POP department under Dr. Winterstein ’s supervision. Currently she is also an instructor at HUTECH University Faculty of Pharmacy in Vietnam. Prior […]